The anti-tumor immune response involves a series of complex steps mediated by various immune cells and signaling molecules.
World-renowned Immunologist and Distinguished Scientist Joins CancerVax as Senior Scientific Advisor
Dr. Mark Davis, discoverer of the first T-cell receptor genes and Stanford Professor, to advise the Company on immunological strategies for its novel cancer treatment platform ...
Therapies market, valued at USD 16.7 million in 2024, is expected to register robust revenue CAGR of 44.6%.Request free copy of this report: 13, 2026- The growing incidence of autoimmune disorders ...
To thrive beyond rare disease, cell and gene therapy developers must scale-up manufacturing and commercialisation.
Hong Kong-based biomed pioneer is at the forefront in a global race to develop cell and gene treatments for cancers and other ...
The interferon regulatory factor (IRF) family of transcription factors, pivotal for initiating antiviral type I interferon ...
The Warburg effect describes how cancer cells switch from oxidative phosphorylation to glycolysis even in oxygen-rich conditions, producing massive amounts of lactate that accumulate in the tumor ...
Approval of ANKTIVA was granted for BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ, with ...
Published on January 6, 2026, in Volume 2 of the Immunity & Inflammation journal, the review begins by underscoring Professor Taniguchi's ...
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...
Silica nanomaterial cuts immunotherapy costs while boosting cancer treatment efficacy by nearly 70% in animal studies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback